These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 15343386
1. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. Trouw LA, Groeneveld TW, Seelen MA, Duijs JM, Bajema IM, Prins FA, Kishore U, Salant DJ, Verbeek JS, van Kooten C, Daha MR. J Clin Invest; 2004 Sep; 114(5):679-88. PubMed ID: 15343386 [Abstract] [Full Text] [Related]
2. Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of antimouse C1q antibodies. Trouw LA, Seelen MA, Duijs JM, Benediktsson H, Van Kooten C, Daha MR. Clin Exp Immunol; 2003 Apr; 132(1):32-9. PubMed ID: 12653833 [Abstract] [Full Text] [Related]
4. Glomerular C1q deposition and serum anti-C1q antibodies in anti-glomerular basement membrane disease. Hu SY, Jia XY, Yang XW, Yu F, Cui Z, Zhao MH. BMC Immunol; 2013 Sep 21; 14():42. PubMed ID: 24053688 [Abstract] [Full Text] [Related]
5. Autoantibodies to the collagen-like region of C1Q deposit in glomeruli via C1Q in immune deposits. Uwatoko S, Gauthier VJ, Mannik M. Clin Immunol Immunopathol; 1991 Nov 21; 61(2 Pt 1):268-73. PubMed ID: 1914260 [Abstract] [Full Text] [Related]
6. Anti-C1q autoantibodies in murine lupus nephritis. Trouw LA, Seelen MA, Visseren R, Duijs JM, Benediktsson H, de Heer E, Roos A, van Kooten C, Daha MR. Clin Exp Immunol; 2004 Jan 21; 135(1):41-8. PubMed ID: 14678263 [Abstract] [Full Text] [Related]
7. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis. Sjöwall C, Olin AI, Skogh T, Wetterö J, Mörgelin M, Nived O, Sturfelt G, Bengtsson AA. Autoimmunity; 2013 May 21; 46(3):205-14. PubMed ID: 23331132 [Abstract] [Full Text] [Related]
8. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis]. Zhang FC, Zhou B, Dong Y. Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):955-9. PubMed ID: 16061001 [Abstract] [Full Text] [Related]
9. Immune deposition of C1q and anti-C1q antibodies in the kidney is dependent on the presence of glomerular IgG. Trouw LA, Duijs JM, van Kooten C, Daha MR. Mol Immunol; 2003 Dec 13; 40(9):595-602. PubMed ID: 14597162 [Abstract] [Full Text] [Related]
10. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M. Ann N Y Acad Sci; 2005 Jun 13; 1050():193-200. PubMed ID: 16014534 [Abstract] [Full Text] [Related]
11. Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Mannik M, Wener MH. Arthritis Rheum; 1997 Aug 13; 40(8):1504-11. PubMed ID: 9259432 [Abstract] [Full Text] [Related]
12. Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis. Tan Y, Song D, Wu LH, Yu F, Zhao MH. BMC Nephrol; 2013 Mar 19; 14():63. PubMed ID: 23510032 [Abstract] [Full Text] [Related]
13. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay. Vanhecke D, Roumenina LT, Wan H, Osthoff M, Schaller M, Trendelenburg M. Arthritis Rheum; 2012 Nov 19; 64(11):3706-14. PubMed ID: 22740328 [Abstract] [Full Text] [Related]
14. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients. Tsacheva I, Radanova M, Todorova N, Argirova T, Kishore U. Mol Immunol; 2007 Mar 19; 44(8):2147-51. PubMed ID: 17049989 [Abstract] [Full Text] [Related]
15. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells. Bigler C, Schaller M, Perahud I, Osthoff M, Trendelenburg M. J Immunol; 2009 Sep 01; 183(5):3512-21. PubMed ID: 19648280 [Abstract] [Full Text] [Related]
16. Nucleosomes and C1q bound to glomerular endothelial cells serve as targets for autoantibodies and determine complement activation. O'Flynn J, Flierman R, van der Pol P, Rops A, Satchell SC, Mathieson PW, van Kooten C, van der Vlag J, Berden JH, Daha MR. Mol Immunol; 2011 Oct 01; 49(1-2):75-83. PubMed ID: 21855148 [Abstract] [Full Text] [Related]
17. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro. Pang Y, Yang XW, Song Y, Yu F, Zhao MH. Immunobiology; 2014 Dec 01; 219(12):980-9. PubMed ID: 25092568 [Abstract] [Full Text] [Related]
18. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways. Thanei S, Vanhecke D, Trendelenburg M. Clin Immunol; 2015 Oct 01; 160(2):180-7. PubMed ID: 26148903 [Abstract] [Full Text] [Related]
19. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients. Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, Baba S, Hara M, Yamanaka H. Arthritis Rheum; 2011 Aug 01; 63(8):2436-44. PubMed ID: 21506094 [Abstract] [Full Text] [Related]
20. Autoreactivity to mouse C1q in a murine model of SLE. Trinder PK, Maeurer MJ, Schorlemmer HU, Loos M. Rheumatol Int; 1995 Aug 01; 15(3):117-20. PubMed ID: 8588121 [Abstract] [Full Text] [Related] Page: [Next] [New Search]